Evidence map›Paper›PMID 26540051›Full record

ArticleInternational journal of molecular sciences2015

Genotoxicity of Superparamagnetic Iron Oxide Nanoparticles in Granulosa Cells.

Marina Pöttler, Andreas Staicu, Jan Zaloga, Harald Unterweger, Bianca Weigel, Eveline Schreiber, Simone Hofmann, Irmi Wiest, Udo Jeschke, Christoph Alexiou and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Marina PöttlerDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. marina.poettler@uk-erlangen.de.
Andreas StaicuDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. andreas.staicu@uk-erlangen.de.
Jan ZalogaDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. jan.zaloga@uk-erlangen.de.
Harald UnterwegerDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. harald.unterweger@uk-erlangen.de.
Bianca WeigelDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. bianca.weigel@uk-erlangen.de.
Eveline SchreiberDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. eveline.schreiber@uk-erlangen.de.
Simone HofmannDepartment of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistraße 11, Munich 80337, Germany. simone.hofmann@med.uni-muenchen.de.
Irmi WiestDepartment of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistraße 11, Munich 80337, Germany. irmgard.wiest@med.uni-muenchen.de.
Udo JeschkeDepartment of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Maistraße 11, Munich 80337, Germany. udo.jeschke@med.uni-muenchen.de.
Christoph AlexiouDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. christoph.alexiou@uk-erlangen.de.
Christina JankoDepartment of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, University Hospital Erlangen, Glückstraße 10a, Erlangen 91054, Germany. christina.janko@uk-erlangen.de.
Universitätsklinikum Erlangen · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles that are aimed at targeting cancer cells, but sparing healthy tissue provide an attractive platform of implementation for hyperthermia or as carriers of chemotherapeutics. According to the literature, diverse effects of nanoparticles relating to mammalian reproductive tissue are described. To address the impact of nanoparticles on cyto- and genotoxicity concerning the reproductive system, we examined the effect of superparamagnetic iron oxide nanoparticles (SPIONs) on granulosa cells, which are very important for ovarian function and female fertility. Human granulosa cells (HLG-5) were treated with SPIONs, either coated with lauric acid (SEONLA) only, or additionally with a protein corona of bovine serum albumin (BSA; SEON(LA-BSA)), or with dextran (SEON(DEX)). Both micronuclei testing and the detection of γH2A.X revealed no genotoxic effects of SEON(LA-BSA), SEON(DEX) or SEON(LA). Thus, it was demonstrated that different coatings of SPIONs improve biocompatibility, especially in terms of genotoxicity towards cells of the reproductive system.

Indexed as

Cell LineCell SurvivalDextransDNA DamageFemaleFerric CompoundsGranulosa CellsHumansMagnetite NanoparticlesMicronuclei, Chromosome-DefectiveMutagenicity TestsDextransFerric Compoundsferric oxideferumoxidesMagnetite Nanoparticlescancer therapy and diagnosisgranulosa cellsprotein coronareproductive healthsuperparamagnetic iron oxide nanoparticles

Identifiers

PMID26540051
PMCPMC4661819
OpenAlexW2109047828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.